Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Prostate

Showing results (1111-1120 of 5,911) with videos related to

Pageof 592
Sort By:
The Prostate|November 23, 2017
Current or recent smoking is associated with more variable telomere length in prostate stromal cells and prostate cancer cellsCorinne E Joshu, Sarah B Peskoe, Christopher M Heaphy, et al.
The Prostate|November 29, 2017
Genetic factors influencing prostate cancer risk in Norwegian menHaitao Chen, Charles M Ewing, Sigun Zheng, et al.
The Prostate|November 15, 2017
Altered mitochondrial genome content signals worse pathology and prognosis in prostate cancerAnton M F Kalsbeek, Eva K F Chan, Judith Grogan, et al.
The Prostate|December 2, 2017
A carbon 21 steroidal metabolite from progestin, 20β-hydroxy-5α-dihydroprogesterone, stimulates the androgen receptor in prostate cancer cellsTakashi Ando, Tsutomu Nishiyama, Itsuhiro Takizawa, et al.
The Prostate|September 15, 2017
Hyperactive mTOR induces neuroendocrine differentiation in prostate cancer cell with concurrent up-regulation of IRF1Mayuko Kanayama, Toshiya Hayano, Michinori Koebis, et al.
The Prostate|September 15, 2017
Impact of five-tiered Gleason grade groups on prognostic prediction in clinical stage T3 prostate cancer undergoing high-dose-rate brachytherapyHideyasu Tsumura, Hiromichi Ishiyama, Ken-Ichi Tabata, et al.
The Prostate|January 1, 1989
Regional distribution of opioidergic nerves in human and canine prostatesG Aumüller, T Jungblut, B Malek, et al.
The Prostate|June 22, 2016
Phase I Trial of Anti-PSMA Designer CAR-T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2-T Cell Pharmacodynamics as a Determinant of Clinical ResponseRichard P Junghans, Qiangzhong Ma, Ritesh Rathore, et al.
The Prostate|June 22, 2016
A Pilot Study of Clinical Targeted Next Generation Sequencing for Prostate Cancer: Consequences for Treatment and Genetic CounselingHeather H Cheng, Nola Klemfuss, Bruce Montgomery, et al.
The Prostate|November 5, 2020
Early-onset prostate cancer is associated with increased risks of disease progression and cancer-specific mortalityHung-Jen Shih, Su-Chen Fang, Lu An, et al.
Pageof 592

Showing results (1111-1120 of 5,911) with videos related to

Sort By:
Pageof 592
The Prostate|November 23, 2017
Current or recent smoking is associated with more variable telomere length in prostate stromal cells and prostate cancer cellsCorinne E Joshu, Sarah B Peskoe, Christopher M Heaphy, et al.
The Prostate|November 29, 2017
Genetic factors influencing prostate cancer risk in Norwegian menHaitao Chen, Charles M Ewing, Sigun Zheng, et al.
The Prostate|November 15, 2017
Altered mitochondrial genome content signals worse pathology and prognosis in prostate cancerAnton M F Kalsbeek, Eva K F Chan, Judith Grogan, et al.
The Prostate|December 2, 2017
A carbon 21 steroidal metabolite from progestin, 20β-hydroxy-5α-dihydroprogesterone, stimulates the androgen receptor in prostate cancer cellsTakashi Ando, Tsutomu Nishiyama, Itsuhiro Takizawa, et al.
The Prostate|September 15, 2017
Hyperactive mTOR induces neuroendocrine differentiation in prostate cancer cell with concurrent up-regulation of IRF1Mayuko Kanayama, Toshiya Hayano, Michinori Koebis, et al.
The Prostate|September 15, 2017
Impact of five-tiered Gleason grade groups on prognostic prediction in clinical stage T3 prostate cancer undergoing high-dose-rate brachytherapyHideyasu Tsumura, Hiromichi Ishiyama, Ken-Ichi Tabata, et al.
The Prostate|January 1, 1989
Regional distribution of opioidergic nerves in human and canine prostatesG Aumüller, T Jungblut, B Malek, et al.
The Prostate|June 22, 2016
Phase I Trial of Anti-PSMA Designer CAR-T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2-T Cell Pharmacodynamics as a Determinant of Clinical ResponseRichard P Junghans, Qiangzhong Ma, Ritesh Rathore, et al.
The Prostate|June 22, 2016
A Pilot Study of Clinical Targeted Next Generation Sequencing for Prostate Cancer: Consequences for Treatment and Genetic CounselingHeather H Cheng, Nola Klemfuss, Bruce Montgomery, et al.
The Prostate|November 5, 2020
Early-onset prostate cancer is associated with increased risks of disease progression and cancer-specific mortalityHung-Jen Shih, Su-Chen Fang, Lu An, et al.
Pageof 592